Post-translational modifications of intrinsically disordered regions (IDRs) enable changes in sequence chemistry, which in turn can tune conformational behavior and molecular interactions. In this issue of The EMBO Journal, Gruijs da Silva et al disentangle the effect of hyperphosphorylation on the C-terminal domain of TDP-43, a key IDR implicated in Amyotrophic Lateral Sclerosis (ALS).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016343 | PMC |
| http://dx.doi.org/10.15252/embj.2022111062 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Replication protein A (RPA) is a heterotrimeric single-strand DNA binding protein that is integral to DNA metabolism. Segregation of RPA functions in response to DNA damage is fine-tuned by hyperphosphorylation of the RPA32 subunit that is dependent on Cyclin-dependent kinase (Cdk)-mediated priming phosphorylation at the Ser-23 and Ser-29 sites. However, the mechanism of priming-driven hyperphosphorylation of RPA remains unresolved.
View Article and Find Full Text PDFEstrogen receptor β exerts neuroprotective effects by fine-tuning mitochondrial homeostasis through NRF1/PGC-1α.
Neurochem Int
October 2023
Institute of Pharmacology, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, 271021, China. Electronic address:
Article Synopsis
- Estrogen deficiency in postmenopausal mice leads to mitochondrial defects and cognitive decline associated with Alzheimer's disease, prompting research on estrogen receptor β (ERβ) as a potential protective factor.
- The study used ovariectomized 3xTg-AD mice, with some treated with an ERβ agonist, to assess cognitive function and measure numerous proteins linked to mitochondrial health and neuronal apoptosis.
- Findings revealed that reducing ERβ expression led to cognitive impairment and increased mitochondrial damage, while the ERβ agonist helped alleviate cognitive decline and improve mitochondrial function, suggesting ERβ's key role in neural protection against AD.
An artificial protein modulator reprogramming neuronal protein functions.
Nat Commun
March 2024
Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, School of Biomedical Engineering, National Center for Translational Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University, Shanghai, 200240, China.
Article Synopsis
- Reversible protein phosphorylation is essential for regulating protein functions and is linked to various biological processes, with its dysregulation potentially leading to diseases.
- The text discusses the development of artificial protein modulators (APROMs) designed to mimic protein phosphatases, which can reverse harmful post-translational modifications for therapeutic purposes.
- These APROMs specifically target hyperphosphorylated α-synuclein, enhancing synaptic function and offering potential treatment strategies for conditions like Parkinson's disease.
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons.
NPJ Parkinsons Dis
September 2022
Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
α-Synuclein (αSyn) aggregation in Lewy bodies and neurites defines both familial and 'sporadic' Parkinson's disease. We previously identified α-helically folded αSyn tetramers, in addition to the long-known unfolded monomers, in normal cells. PD-causing αSyn mutations decrease the tetramer:monomer (T:M) ratio, associated with αSyn hyperphosphorylation and cytotoxicity in neurons and a motor syndrome of tremor and gait deficits in transgenic mice that responds in part to L-DOPA.
View Article and Find Full Text PDFHyperphosphorylation tunes TDP-43 solubility.
EMBO J
April 2022
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.
Post-translational modifications of intrinsically disordered regions (IDRs) enable changes in sequence chemistry, which in turn can tune conformational behavior and molecular interactions. In this issue of The EMBO Journal, Gruijs da Silva et al disentangle the effect of hyperphosphorylation on the C-terminal domain of TDP-43, a key IDR implicated in Amyotrophic Lateral Sclerosis (ALS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!